Monosodium urate activates Src/Pyk2/PI3 kinase and cathepsin dependent unconventional protein secretion from human primary macrophages

单尿酸钠激活人类原代巨噬细胞中 Src/Pyk2/PI3 激酶和蛋白酶依赖性非常规蛋白质分泌

阅读:17
作者:Elina Välimäki, Juho J Miettinen, Niina Lietzén, Sampsa Matikainen, Tuula A Nyman

Abstract

Monosodium urate (MSU) is an endogenous danger signal that is crystallized from uric acid released from injured cells. MSU is known to activate inflammatory response in macrophages but the molecular mechanisms involved have remained uncharacterized. Activated macrophages start to secrete proteins to activate immune response and to recruit other immune cells to the site of infection and/or tissue damage. Secretome characterization after activation of innate immune system is essential to unravel the details of early phases of defense responses. Here, we have analyzed the secretome of human primary macrophages stimulated with MSU using quantitative two-dimensional gel electrophoresis based proteomics as well as high-throughput qualitative GeLC-MS/MS approach combining protein separation by SDS-PAGE and protein identification by liquid chromatography-MS/MS. Both methods showed that MSU stimulation induced robust protein secretion from lipopolysaccharide-primed human macrophages. Bioinformatic analysis of the secretome data showed that MSU stimulation strongly activates unconventional, vesicle mediated protein secretion. The unconventionally secreted proteins included pro-inflammatory cytokines like IL-1β and IL-18, interferon-induced proteins, and danger signal proteins. Also active forms of lysosomal proteases cathepsins were secreted on MSU stimulation, and cathepsin activity was essential for MSU-induced unconventional protein secretion. Additionally, proteins associated to phosphorylation events including Src family tyrosine kinases were increased in the secretome of MSU-stimulated cells. Our functional studies demonstrated that Src, Pyk2, and PI3 kinases act upstream of cathepsins to activate the overall protein secretion from macrophages. In conclusion, we provide the first comprehensive characterization of protein secretion pathways activated by MSU in human macrophages, and reveal a novel role for cathepsins and Src, Pyk2, PI3 kinases in the activation of unconventional protein secretion.

文献解析

1. 文献背景信息

  • ​标题/作者/期刊/年份​​:

    • 标题:Monosodium urate activates Src/Pyk2/PI3 kinase and cathepsin dependent unconventional protein secretion from human primary macrophages

    • 作者:Elina Välimäki, Juho J Miettinen, Niina Lietzén, Sampsa Matikainen, Tuula A Nyman

    • 期刊:Molecular & Cellular Proteomics(IF=6.100)

    • 年份:2013

    • ​权威性与时效性​​:发表于中高影响力期刊,虽为2013年研究,但涉及痛风/炎症领域的基础机制,部分结论可能仍具参考价值。

  • ​研究领域与背景​​:

    • 领域:先天免疫与炎症反应,聚焦尿酸钠(MSU)晶体(痛风关键致病因子)激活巨噬细胞的分子机制。

    • 研究现状:MSU已知可触发炎症(如NLRP3炎性小体激活),但其调控蛋白质非常规分泌(UPS)的机制尚不明确。

  • ​研究动机​​:

    • 填补空白:首次系统解析MSU诱导人原代巨噬细胞UPS的途径,揭示Src/Pyk2/PI3K-蛋白酶依赖的新调控轴。


2. 研究问题与假设

  • ​核心问题​​:MSU如何激活巨噬细胞的非常规蛋白质分泌途径?

  • ​假设​​:MSU通过Src/Pyk2/PI3K信号级联和蛋白酶(如组织蛋白酶)活性,驱动UPS(包括IL-1β等炎症因子)。


3. 研究方法学与技术路线

  • ​实验设计​​:

    • 体外刺激实验:LPS预激活的人原代巨噬细胞+MSU处理,分析分泌组。

  • ​关键技术​​:

    • ​定量​​:2D凝胶电泳蛋白质组学;​​定性​​:GeLC-MS/MS(SDS-PAGE分离+LC-MS/MS鉴定)。

    • 功能验证:抑制剂(Src/PI3K/蛋白酶)阻断实验。

  • ​创新方法​​:

    • 首次整合分泌组学与激酶/蛋白酶功能分析,揭示MSU的UPS调控网络。


4. 结果与数据解析

  • ​主要发现​​:

​                      分泌组变化​​:MSU显著增加IL-1β、IL-18、干扰素诱导蛋白及组织蛋白酶分泌(2D凝胶/MS验证)。

​                      关键通路​​:抑制剂实验证实Src/Pyk2/PI3K通路位于组织蛋白酶上游,共同调控UPS(如IL-1β分泌依赖该通路)。

                      ​​机制关联​​:分泌蛋白富集于囊泡介导的UPS途径,且蛋白酶活性为必需条件。

  • ​数据验证​​:多技术交叉验证(蛋白质组学+功能实验),但缺乏体内模型支持。

  • ​局限性​​:仅用LPS预激活细胞,未模拟生理性MSU沉积微环境;样本量未明确说明。


5. 讨论与机制阐释

  • ​机制模型​​:

    MSU→激活Src/Pyk2/PI3K→促进组织蛋白酶释放/活化→切割底物→驱动囊泡介导的UPS(如IL-1β前体加工)。

  • ​与既往研究对比​​:

    • 支持:MSU激活炎症(如NLRP3)的已知结论;

    • 拓展:提出独立于炎性小体的UPS调控新机制。

  • ​未解决问题​​:MSU是否直接磷酸化Src/Pyk2?UPS在痛风炎症中的时空动态?


6. 创新点与学术贡献

  • ​理论创新​​:

    • 首次将MSU与UPS联系,提出“激酶-蛋白酶”协同调控炎症分泌的范式。

  • ​技术贡献​​:

    • 分泌组学策略可推广至其他晶体(如胆固醇)相关炎症研究。

  • ​实际价值​​:

    • 为痛风治疗提供新靶点(如靶向Src/组织蛋白酶);提示UPS在无菌炎症中的广泛作用。


总结

该研究通过多组学与功能实验,揭示了MSU激活巨噬细胞UPS的分子通路,为痛风及炎症性疾病机制研究提供了新视角。后续研究可结合体内模型验证靶点治疗潜力。

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。